TrademarkDir
PATIENT FIRST
LIVE

Serial Number

85807277

Owner

PATIENT FIRST CORPORATION

Attorney

Robert D. Michaux

First Use Date

Nov 30, 2001

Filing Date

Dec 20, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PATIENT FIRST Trademark

Serial Number: 85807277 • Registration: 4518756

PATIENT FIRST is a trademark filed by PATIENT FIRST CORPORATION on December 20, 2012. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PATIENT FIRST CORPORATION (22 trademarks)

5000 COX ROAD, SUITE 100
GLEN ALLEN, VA 23060

Entity Type: 03

Trademark Details

Filing Date

December 20, 2012

Registration Date

April 22, 2014

First Use Anywhere

November 30, 2001

First Use in Commerce

November 30, 2001

Published for Opposition

June 18, 2013

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 17, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 17, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 17, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 17, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 22, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 22, 2023 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2021 REAP
COUNTERCLAIM OPP. NO. 999999
Oct 30, 2020 CCON
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 21, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 21, 2019 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 21, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2019 TCCA
TEAS SECTION 8 & 15 RECEIVED
Nov 12, 2019 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 18, 2019 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 22, 2019 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 18, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Mar 15, 2014 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 14, 2014 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2014 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 12, 2014 SUPC
SOU EXTENSION 1 GRANTED
Mar 12, 2014 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 2, 2014 AITU
SOU EXTENSION 1 FILED
Feb 10, 2014 EXT1
USE AMENDMENT FILED
Feb 10, 2014 IUAF
SOU TEAS EXTENSION RECEIVED
Feb 10, 2014 EEXT
TEAS STATEMENT OF USE RECEIVED
Feb 10, 2014 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 15, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2013 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 13, 2013 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 12, 2013 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 2, 2013 PREV
ASSIGNED TO LIE
May 2, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 12, 2013 GNRN
NON-FINAL ACTION E-MAILED
Apr 12, 2013 GNRT
NON-FINAL ACTION WRITTEN
Apr 12, 2013 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2013 NWOS

Related Trademarks

More from this Owner

PACIENTE PRIMERO

PACIENTE PRIMERO

PACIENTE PRIMERO

PACIENTE PRIMERO

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST

PATIENT FIRST